Barbershop Talk: Reducing Excessive Alcohol Consumption Among Men

March 13, 2026 updated by: University of Arkansas

Unhealthy drinking is considered one of the top 10 public health concerns in the United States. Not only has heavy drinking been linked to poorer overall health and the chances of getting cancer and cardiovascular diseases, but it also causes about 88,000 deaths and 2.5 million years of potential life lost each year in the U.S. Men living in rural areas tend to drink more. In Arkansas, a rural state with high rates of unhealthy drinking, men are more likely to report heavy drinking (4 or more drinks a day) and to drink more when binge drinking. Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an evidence-based, multilevel, integrated public health approach for early intervention and timely referral to more intensive treatment for those with substance use disorders. SBIRTs have been successfully used in primary care and emergency settings.

However, men in rural areas may lack access to evidence-based care for unhealthy drinking due to many factors, including limited healthcare providers and insurance standing. Given the increased chances of death and illness linked to harmful drinking among rural men and the serious health consequences involved, it is urgent to improve access to evidence-based care. This can be achieved by expanding services into community settings that men in rural areas are more likely to visit, such as barbershops. Thus, the goals of this proposed Hybrid Type 2 pragmatic effectiveness-implementation trial are to: 1) test the effectiveness of an evidence-based SBIRT intervention for use within barbershops (Barbershop Talk); and 2) generate the scientific evidence needed to implement SBIRTs in "real world" settings. Data from this study will further our understanding of how to reduce the chances of experiencing alcohol attributable morbidity and mortality among men living in rural areas. Data will also enhance our understanding of strategies that can improve the implementation of evidence-based care models in non-clinical settings, thereby extending the reach of evidence-based care to rural communities with high needs.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

611

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arkansas
      • Little Rock, Arkansas, United States, 72205
        • UAMS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • male
  • aged 18 or older
  • resident of Arkansas

Exclusion Criteria:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SBIRT
Each intervention barbershop, will hold screening days, where a trained community health worker will be onsite to provide Screening, Brief Intervention, and Referral to Treatment (SBIRT).
Low risk individuals will receive an educational pamphlet about alcohol use and the impact on health. Moderate Risk individuals will receive a brief alcohol intervention. High risk individuals will receive the brief alcohol intervention and be referred to specialty treatment.
Other: Usual-care
Six months after completion of Time 1, barbershops in the usual-care arm will receive the intervention.
Low risk individuals will receive an educational pamphlet about alcohol use and the impact on health. Moderate Risk individuals will receive a brief alcohol intervention. High risk individuals will receive the brief alcohol intervention and be referred to specialty treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol Use - total number of drinking days
Time Frame: Baseline

At-risk drinking behavior measured as:

number of drinking days

Baseline
Alcohol Use - total number of drinking days
Time Frame: 3 months

At-risk drinking behavior measured as:

number of drinking days

3 months
Alcohol Use - total number of drinking days
Time Frame: 6 months

At-risk drinking behavior measured as:

number of drinking days

6 months
Alcohol Use - number of unhealthy drinking days
Time Frame: Baseline

At-risk drinking behavior measured as:

number of unhealthy drinking days

Baseline
Alcohol Use - number of unhealthy drinking days
Time Frame: 3 months

At-risk drinking behavior measured as:

number of unhealthy drinking days

3 months
Alcohol Use - total number of unhealthy drinking days
Time Frame: 6 months

At-risk drinking behavior measured as:

number of unhealthy drinking days

6 months
Mental Health - depression
Time Frame: Baseline
The PHQ-9 is the depression module of the Patient Health Questionnaire (a diagnostic instrument for common mental disorders), which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The PHQ9 will be used for this outcome.
Baseline
Mental Health - depression
Time Frame: 3 months
The PHQ-9 is the depression module of the Patient Health Questionnaire (a diagnostic instrument for common mental disorders), which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The PHQ9 will be used for this outcome.
3 months
Mental Health - depression
Time Frame: 6 months
The PHQ-9 is the depression module of the Patient Health Questionnaire (a diagnostic instrument for common mental disorders), which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The PHQ9 will be used for this outcome.
6 months
Mental Health - Posttraumatic Stress Disorder (PTSD)
Time Frame: Baseline
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL5)
Baseline
Mental Health - Posttraumatic Stress Disorder (PTSD)
Time Frame: 3 months
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL5)
3 months
Mental Health - Posttraumatic Stress Disorder (PTSD)
Time Frame: 6 months
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL5)
6 months
Social Support
Time Frame: Baseline
Family, friend, and partner support (number of people in support network)
Baseline
Social Support
Time Frame: 3 months
Family, friend, and partner support (number of people in support network)
3 months
Social Support
Time Frame: 6 months
Family, friend, and partner support (number of people in support network)
6 months
Healthcare Utilization
Time Frame: Baseline
Number of subjects who have utilized healthcare services
Baseline
Healthcare Utilization
Time Frame: 3 months
Number of subjects who have utilized healthcare services
3 months
Healthcare Utilization
Time Frame: 6 months
Number of subjects who have utilized healthcare services
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tiffany F Haynes, PhD, University of Arkansas

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 26, 2023

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

July 31, 2027

Study Registration Dates

First Submitted

October 17, 2022

First Submitted That Met QC Criteria

November 1, 2022

First Posted (Actual)

November 8, 2022

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 13, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 273439

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drinking Behavior

Clinical Trials on SBIRT

Subscribe